Kinase modulation and indications therefor
作者： Gideon Bollag , Prabha N. Ibrahim , Guoxian Wu , Gaston Habets , Jiazhong Zhang
DOI:
关键词:
摘要: The present disclosure provides methods of using protein kinase inhibitors for treating diseases and conditions, including conditions associated with activity any selected from Fms mutations thereof, Kit Flt-3 thereof combinations thereof.
glgoo.top参考文章(125)
Marika Nespi, Wayne Spevak, Klaus-Peter Hirth, Prabha N. Ibrahim, Songyuan Shi, Betsy Burton, Gaston G. Habets, Chao Zhang, Compounds for kinase modulation, and indications therefor ,(2014)
Wayne Spevak, Hanna Cho, Prabha N. Ibrahim, Hongyao Zhu, Pyrrolo[2,3-]pyridine kinase inhibitors ,(2010)
Richard A. Ford, Arnold J. Gordon, The Chemist's Companion: A Handbook of Practical Data, Techniques, and References ,(1972)
P. Tijssen, Theory and nucleic acid preparation Elsevier. ,(1993)
Karen Cichowski, Rapamycin compounds in the treatment of neurofibromatosis type 1 ,(2005)
David S. Smith, Immunoassay for gentamicin ,(1977)
Ralph Diodone, Prabha N. Ibrahim, Urs Schwitter, Shan-Ming Kuang, Baoshu Zhao, Gary Conard Visor, Karsten Faehnrich, Solid forms of a pharmaceutically active substance ,(2012)
Shohei Yokota, Nucleic acid encoding receptor type protein kinase ,(1997)
Alfonso R. Gennaro, Remington: The Science and Practice of Pharmacy ,(2003)